Macroporous hydrogel micropillars for quantifying Met kinase activity in cancer cell lysates

作者: Alicia D. Powers , Bi Liu , Andrew G. Lee , Sean P. Palecek

DOI: 10.1039/C2AN35464K

关键词: Cancer researchAkt/PKB signaling pathwayP70-S6 Kinase 1Kinase activityProto-Oncogene Proteins c-metProtein kinase BMolecular biologyCyclin-dependent kinase 6Cancer cellChemistryKinase

摘要: Overactive and overexpressed kinases have been implicated in the cause progression of many cancers. Kinase inhibitors offer a targeted approach for treating cancers associated with increased or deregulated kinase activity. Often, however, cancer cells exhibit initial resistance to these evolve develop during treatment. Additionally, any one tissue type are typically heterogeneous their oncogenesis mechanisms, thus diagnosis particular does not necessarily provide insight into what therapies may be effective. For example, while some lung that overexpress epidermal growth factor receptor (EFGR) respond treatment EGFR inhibitors, overexpression hyperactivity Met correlates inhibitors. Here we describe microfluidic-based assay quantifying activity cell lysates eventual goals predicting responsiveness monitoring development In this assay, immobilized phosphorylation substrate macroporous hydrogel micropillars. We then exposed micropillars lysate detected using fluorescently conjugated antibody. This is able quantify whole from as few 150 cells. It can also detect expressing overactive background up 75% non-cancerous inhibition by Met-specific SU11274 PHA665752, suggesting predictive capability cellular response

参考文章(47)
Doriano Fabbro, Sandra W. Cowan-Jacob, Henrik Möbitz, Georg Martiny-Baron, Targeting cancer with small-molecular-weight kinase inhibitors. Methods of Molecular Biology. ,vol. 795, pp. 1- 34 ,(2012) , 10.1007/978-1-61779-337-0_1
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
John R. ZALCBERG, Jayesh DESAI, Dose optimization of tyrosine kinase inhibitors to improve outcomes in GIST Asia-pacific Journal of Clinical Oncology. ,vol. 8, pp. 43- 52 ,(2012) , 10.1111/J.1743-7563.2011.01491.X
Christiane R. Maroun, Marina Holgado-Madruga, Isabelle Royal, Monica A. Naujokas, Tanya M. Fournier, Albert J. Wong, Morag Park, The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase Molecular and Cellular Biology. ,vol. 19, pp. 1784- 1799 ,(1999) , 10.1128/MCB.19.3.1784
André A. Adams, Paul I. Okagbare, Juan Feng, Matuesz L. Hupert, Don Patterson, Jost Göttert, Robin L. McCarley, Dimitris Nikitopoulos, Michael C. Murphy, Steven A. Soper, Highly Efficient Circulating Tumor Cell Isolation from Whole Blood and Label-Free Enumeration Using Polymer-Based Microfluidics with an Integrated Conductivity Sensor Journal of the American Chemical Society. ,vol. 130, pp. 8633- 8641 ,(2008) , 10.1021/JA8015022
Shawn B. Brueggemeier, Ding Wu, Stephen J. Kron, Sean P. Palecek, Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates. Biomacromolecules. ,vol. 6, pp. 2765- 2775 ,(2005) , 10.1021/BM050257V
Takafumi Kubo, Hiromasa Yamamoto, William W. Lockwood, Ilse Valencia, Junichi Soh, Michael Peyton, Masaru Jida, Hiroki Otani, Tetsuya Fujii, Mamoru Ouchida, Nagio Takigawa, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, John D. Minna, Marileila Varella-Garcia, Wan L. Lam, Adi F. Gazdar, Shinichi Toyooka, MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. International Journal of Cancer. ,vol. 124, pp. 1778- 1784 ,(2009) , 10.1002/IJC.24150
Fabiola Cecchi, Daniel C. Rabe, Donald P. Bottaro, Targeting the HGF/Met signalling pathway in cancer. European Journal of Cancer. ,vol. 46, pp. 1260- 1270 ,(2010) , 10.1016/J.EJCA.2010.02.028
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, T. Kosaka, A. J. Holmes, A. M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B. E. Johnson, L. C. Cantley, P. A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science. ,vol. 316, pp. 1039- 1043 ,(2007) , 10.1126/SCIENCE.1141478